News

SEC Filings

Document Details

Filing Date
February 26, 2024
Document Date
February 26, 2024
Form Description
Written public communication relating to an issuer or third party tender offer
Filing Group
Mergers & Acquisitions
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com